EN PL
 
EN PL
Bieżący numer
Archiwum
Online first
O czasopiśmie
Dla autorów
Książki i Konferencje
6/2016 vol. 54
Pobierz cytowanie
PRACA PRZEGLĄDOWA
Recognizing Systemic Sclerosis: comparative analysis of various sets of classification criteria
Katarzyna Romanowska-Próchnicka
,
 
Marcela Walczyk
,
 
Marzena Olesińska
 
 
 
Więcej
Ukryj
 
Data nadesłania: 11-10-2016
 
 
Data ostatniej rewizji: 08-11-2016
 
 
Data akceptacji: 18-12-2016
 
 
Data publikacji online: 30-12-2016
 
 
Data publikacji: 30-12-2016
 
 
Reumatologia 2016;54(6):296-305
DOI: https://doi.org/10.5114/reum.2016.64906
 
 
Artykuł (PDF)
Referencje (48)
 
SŁOWA KLUCZOWE
systemic sclerosis
new classification ACR/EULAR criteria 2013
1980 ACR classification criteria
 
DZIEDZINY
Twardzina układowa, myositis i powiązane zespoły - etiologia, patogeneza, obraz kliniczny i leczenie
 
STRESZCZENIE
Systemic sclerosis is a complex disease characterized by autoimmunity, vasculopathy and tissue fibrosis. Although most patients present with some degree of skin sclerosis, which is a distinguishing hallmark, the clinical presentation vary greatly complicating the diagnosis. In this regard, new classification criteria were jointly published in 2013 by American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR). A recent major development in the classification criteria is improved sensitivity, particularly for detecting early disease. The new criteria allow more cases to be classified as having systemic sclerosis (SSc), which leads to earlier treatment. Moreover it is clinically beneficial in preventing the disease progression with its irreversible fibrosis and organ damage. The aim of this review is to give insight into new classification criteria and current trends in the diagnosis of systemic sclerosis.
 
REFERENCJE (48)
1.
Hoogen F, Khanna D, Johnson SR, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-2747.
Google Scholar
 
 
2.
Jordan S, Maurer B, Toniolo M, et al. Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice. Rheumatology (Oxford) 2015; 54: 1454-1458.
Google Scholar
 
 
3.
Alhajeri H, Hudson M, Fritzler M, et al. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.Arthritis Care Res (Hoboken) 2015; 67: 582-587.
Google Scholar
 
 
4.
Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken) 2015; 67: 891-897.
Google Scholar
 
 
5.
Lonzetti LS, Joyal F, Raynauld JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-736.
Google Scholar
 
 
6.
Nadashkevich O, Davis P, Fritzler MJ. A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 2004; 10: CR615-621.
Google Scholar
 
 
7.
LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-1578.
Google Scholar
 
 
8.
Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis 2011; 70: 476-481.
Google Scholar
 
 
9.
Clements PJ1, Hurwitz EL, Wong WK, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000; 43: 2445-2454.
Google Scholar
 
 
10.
Shand L, Lunt M. Relationship Between Change in Skin Score and Disease Outcome in Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatism 2007; 56: 2422-2431.
Google Scholar
 
 
11.
Czirják L, Foeldvari I, Müller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (Oxford) 2008; 47 Suppl 5: v44-45.
Google Scholar
 
 
12.
Gerbracht DD, Steen VD, Ziegler GL, et al. Evolution of primary Raynaud’s phenomenon (Raynaud’s disease) to connective tissue disease. Arthritis Rheum 1985; 28: 87-92.
Google Scholar
 
 
13.
Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58: 3902-3912.
Google Scholar
 
 
14.
Minier T, Guiducci S, Bellando-Randone S, et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 2014; 73: 2087-2093.
Google Scholar
 
 
15.
Bruni C, Guiducci S, Bellando-Randone S, et al. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis. Rheumatology (Oxford) 2015; 54: 72-76.
Google Scholar
 
 
16.
Zhang SZ, Xu D, Li MT, et al. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China. Clin Exp Rheumatol 2015; 33 (4 Suppl 91): S106-110.
Google Scholar
 
 
17.
Pope JE. The Diagnosis and Treatment of Raynaud’s Phenomenon. A Practical Approach. Drugs 2007; 67: 517-525.
Google Scholar
 
 
18.
Moinzadeh P, Howell KJ, Ong V, et al. Progression of Isolated Raynaud’s Phenomenon to Systemic Sclerosis: Impact of ANA Subtype And Disease Subset [abstract]. Arthritis Rheum 2011; 63 Suppl 10: 677.
Google Scholar
 
 
19.
Ingegnoli F, Gualtierotti R, Orenti A, et al. Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud’s Phenomenon. J Immunol Res 2015; Article ID 371960.
Google Scholar
 
 
20.
Valentini G, Vettori S, Cuomo G, et al. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther 2012; 4: R188.
Google Scholar
 
 
21.
Spencer-Green G. Outcomes in primary Raynaud phenomenon: a metaanalysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158: 595-600.
Google Scholar
 
 
22.
Herrick AL, Cutolo M. Clinical implications from capillaroscopic analysis in patients with Raynaud’s phenomenon and systemic sclerosis. Arthritis Rheum 2010; 62: 2595-2604.
Google Scholar
 
 
23.
Cutolo M, Pizzorni C, Tuccio M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 719-726.
Google Scholar
 
 
24.
Caramaschi P, Canestrini S, Martinelli N, et al. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 2007; 46: 1566-1569.
Google Scholar
 
 
25.
Pucinelli ML, Atra E, Sato EI, et al. Nailfold capillaroscopy in systemic sclerosis: correlations with involvement of lung and esophagus. Rev Bras Rheumatol 1995; 35: 136-142.
Google Scholar
 
 
26.
Groen H, Wichers G, ter Borg EJ, et al. Pulmonary diffusing capacity disturbances are related to nailfold capillaroscopy changes in patients with Raynaud›s phenomenon with and without an underlying connective tissue disease. Am.
Google Scholar
 
 
27.
J Med 1990; 89: 34-41.
Google Scholar
 
 
28.
Bredemeier M, Xavier RM, Capobianco KG, et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31: 286-294.
Google Scholar
 
 
29.
Sebastiani M, Manfredi A, Colaci M, et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009; 61: 688-694.
Google Scholar
 
 
30.
Kayser C1, Sekiyama JY, Próspero LC, et al. Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis. Clin Exp Rheumatol 2013; 31 (2 Suppl 76): 103-108.
Google Scholar
 
 
31.
Salazar GA, Assassi S, Wigley F, et al. Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum 2015; 44: 680-686.
Google Scholar
 
 
32.
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension European Heart Journal doi:10.1093/eurheartj/ehv317.
CrossRef
 
Google Scholar
 
 
33.
Steen V, Medsger TA. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 516-522.
Google Scholar
 
 
34.
Schreiber BE, Valerio CJ, Keir GJ, et al. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. Arthritis Rheum 2011; 63: 3531-3539.
Google Scholar
 
 
35.
Coghlan JG, Denton CP, Grunig E, et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014; 73: 1340-1349.
Google Scholar
 
 
36.
Williams MH, Handler CE, Akram R, et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006; 27: 1485-1494.
Google Scholar
 
 
37.
Cavagna L, Caporali R, Klersy C, et al. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. J Rheumatol 2010; 37: 2064-2070.
Google Scholar
 
 
38.
Allanore Y, Borderie D, Avouac J, et al. High N-terminal probrain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 284-291.
Google Scholar
 
 
39.
Avouac J, Huscher D, Furst DE, et al. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis. Ann Rheum Dis 2014; 73: 191-197.
Google Scholar
 
 
40.
http://detect-pah.com/ access: 08.11.2016.
Google Scholar
 
 
41.
Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165: 1581-1586.
Google Scholar
 
 
42.
Bruni C, Guiducci S, Bellando-Randone S, et al. Digital ulcers as a sentinel sign for early internalorgan involvement in very early systemic sclerosis. Rheumatology 2015; 54: 72-76.
Google Scholar
 
 
43.
Valentini G, Marcoccia A, Cuomo G. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity. Arthritis Care Res (Hoboken) 2014; 66: 1520-1527.
Google Scholar
 
 
44.
D’Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-440.
Google Scholar
 
 
45.
Legnani D, Rizzi M, Sarzi-Puttini P, et al. Diffusing Pulmonary Capacity Measured During Effort: A Possible Early Marker of Pulmonary Involvement In Systemic Sclerosis. Isr Med Assoc J 2015; 17: 739-743.
Google Scholar
 
 
46.
Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunctionin the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010; 69: 218-221.
Google Scholar
 
 
47.
Lee JJ, Pope JE. Diagnosis and Management of Systemic Sclerosis: A Practical Approach. Drugs 2016; 76: 203-213.
Google Scholar
 
 
48.
Castro SV, Jimenez SA. Biomarkers in systemic sclerosis. Biomark Med 2010; 4: 133-147.
Google Scholar
 
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Udostępnij
Wyślij mailem
ARTYKUŁ POWIĄZANY
Nutritional disorders and nutrition-related conditions: an underestimated clinical problem in systemic sclerosis
Rituximab in combination with mycophenolate mofetil in a patient with rapidly progressive systemic sclerosis and cyclophosphamide cardiotoxicity
Digital ischaemia associated with paraneoplastic systemic sclerosis
Osteoporosis in systemic sclerosis patients – retrospective analysis
Uveal complications in the course of systemic sclerosis: A clinical case
Indeksy
 
Indeks słów kluczowych
Indeks dziedzin
Indeks autorów
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
© 2006-2024 Journal hosting platform by Bentus
Scroll to top